Asahi Intecc Co., Ltd. (AHICF)
USD 16.17
(0.0%)
USD 16.17
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 31.85 Billion JPY | 18.72% |
| 2023 | 26.73 Billion JPY | 11.39% |
| 2022 | 22.6 Billion JPY | 31.57% |
| 2021 | 18.19 Billion JPY | 9.87% |
| 2020 | 16.64 Billion JPY | -10.43% |
| 2019 | 18.47 Billion JPY | 10.15% |
| 2018 | 16.78 Billion JPY | 23.21% |
| 2017 | 13.38 Billion JPY | 16.12% |
| 2016 | 11.52 Billion JPY | 12.57% |
| 2015 | 10.35 Billion JPY | 36.12% |
| 2014 | 7.65 Billion JPY | 26.79% |
| 2013 | 5.99 Billion JPY | 9.8% |
| 2012 | 5.49 Billion JPY | -17.76% |
| 2011 | 6.68 Billion JPY | 19.8% |
| 2010 | 5.58 Billion JPY | 38.1% |
| 2009 | 4.04 Billion JPY | 16.66% |
| 2008 | 3.46 Billion JPY | 16.75% |
| 2007 | 2.87 Billion JPY | 19.56% |
| 2006 | 2.48 Billion JPY | 32.6% |
| 2005 | 1.86 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 2.37 Billion JPY | -61.39% |
| 2024 Q3 | 6.19 Billion JPY | 17.62% |
| 2024 Q1 | 8.25 Billion JPY | 170.56% |
| 2024 Q2 | 5.36 Billion JPY | -48.47% |
| 2023 Q2 | 4.7 Billion JPY | -6.29% |
| 2023 FY | - JPY | 11.39% |
| 2023 Q4 | 1.81 Billion JPY | -71.69% |
| 2023 Q1 | 5.02 Billion JPY | 41.21% |
| 2023 Q3 | 6.41 Billion JPY | 36.37% |
| 2022 Q4 | 3.55 Billion JPY | -16.39% |
| 2022 FY | - JPY | 31.57% |
| 2022 Q3 | 4.25 Billion JPY | -11.88% |
| 2022 Q2 | 4.82 Billion JPY | 25.85% |
| 2022 Q1 | 3.83 Billion JPY | 32.3% |
| 2021 Q3 | 4.34 Billion JPY | 64.66% |
| 2021 Q4 | 2.89 Billion JPY | -33.33% |
| 2021 Q2 | 2.64 Billion JPY | -24.38% |
| 2021 FY | - JPY | 9.87% |
| 2021 Q1 | 3.49 Billion JPY | 5126.64% |
| 2020 FY | - JPY | -10.43% |
| 2020 Q4 | -69.45 Million JPY | -101.96% |
| 2020 Q1 | 4.96 Billion JPY | 143.4% |
| 2020 Q2 | 3.91 Billion JPY | -21.05% |
| 2020 Q3 | 3.55 Billion JPY | -9.35% |
| 2019 FY | - JPY | 10.15% |
| 2019 Q4 | 2.03 Billion JPY | -55.1% |
| 2019 Q3 | 4.54 Billion JPY | 28.53% |
| 2019 Q2 | 3.53 Billion JPY | -28.14% |
| 2019 Q1 | 4.91 Billion JPY | 203.01% |
| 2018 Q3 | 3.84 Billion JPY | -6.64% |
| 2018 Q2 | 4.11 Billion JPY | -4.55% |
| 2018 Q1 | 4.31 Billion JPY | 218.49% |
| 2018 Q4 | 1.62 Billion JPY | -57.8% |
| 2018 FY | - JPY | 23.21% |
| 2017 Q3 | 3.48 Billion JPY | 12.22% |
| 2017 Q1 | 3.11 Billion JPY | 282.97% |
| 2017 Q4 | 1.35 Billion JPY | -61.17% |
| 2017 Q2 | 3.1 Billion JPY | -0.35% |
| 2017 FY | - JPY | 16.12% |
| 2016 Q3 | 3.02 Billion JPY | 20.51% |
| 2016 Q1 | 3.09 Billion JPY | 107.03% |
| 2016 FY | - JPY | 12.57% |
| 2016 Q4 | 814.51 Million JPY | -73.08% |
| 2016 Q2 | 2.51 Billion JPY | -18.89% |
| 2015 Q4 | 1.49 Billion JPY | -37.67% |
| 2015 Q1 | 2.22 Billion JPY | 150.83% |
| 2015 FY | - JPY | 36.12% |
| 2015 Q3 | 2.39 Billion JPY | 2.47% |
| 2015 Q2 | 2.34 Billion JPY | 5.27% |
| 2014 Q2 | 1.75 Billion JPY | 12.2% |
| 2014 Q3 | 1.94 Billion JPY | 10.69% |
| 2014 Q4 | 886.49 Million JPY | -54.32% |
| 2014 FY | - JPY | 26.79% |
| 2014 Q1 | 1.56 Billion JPY | 54.58% |
| 2013 Q2 | 1.38 Billion JPY | 26.33% |
| 2013 Q3 | 1.35 Billion JPY | -2.21% |
| 2013 Q4 | 1.01 Billion JPY | -25.64% |
| 2013 FY | - JPY | 9.8% |
| 2013 Q1 | 1.1 Billion JPY | -56.79% |
| 2012 Q3 | 205.85 Million JPY | -71.36% |
| 2012 Q1 | 1.03 Billion JPY | -66.14% |
| 2012 Q2 | 718.8 Million JPY | -30.78% |
| 2012 FY | - JPY | -17.76% |
| 2012 Q4 | 2.54 Billion JPY | 1137.04% |
| 2011 Q3 | 1.39 Billion JPY | 36.7% |
| 2011 Q1 | 1.21 Billion JPY | -48.4% |
| 2011 FY | - JPY | 19.8% |
| 2011 Q4 | 3.06 Billion JPY | 120.44% |
| 2011 Q2 | 1.01 Billion JPY | -15.97% |
| 2010 Q3 | 1.21 Billion JPY | 35.12% |
| 2010 FY | - JPY | 38.1% |
| 2010 Q4 | 2.34 Billion JPY | 93.47% |
| 2010 Q1 | 1.09 Billion JPY | -53.01% |
| 2010 Q2 | 897.74 Million JPY | -17.9% |
| 2009 Q1 | 592.53 Million JPY | 0.0% |
| 2009 Q4 | 2.32 Billion JPY | 176.97% |
| 2009 Q3 | 840.1 Million JPY | 197.85% |
| 2009 Q2 | 282.05 Million JPY | -52.4% |
| 2009 FY | - JPY | 16.66% |
| 2008 FY | - JPY | 16.75% |
| 2007 FY | - JPY | 19.56% |
| 2006 FY | - JPY | 32.6% |
| 2005 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 3304718.27% |
| Ansell Limited | 209.86 Million USD | -15079.072% |
| Ansell Limited | 206.3 Million USD | -15341.105% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -74258.42% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 1960466.805% |
| Psykey, Inc. | -1.29 Million USD | 2459368.249% |
| ConvaTec Group Plc | 455.5 Million USD | -6893.414% |
| ConvaTec Group Plc | 455.5 Million USD | -6893.414% |
| Encision Inc. | -544.19 Thousand USD | 5853700.272% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 22463254.926% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 28977631.156% |
| Innovative MedTech Inc. | -7.67 Million USD | 415212.844% |
| LifePoint, Inc. | -14.2 Million USD | 224397.231% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 514969.888% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 9801638.462% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 14800270.977% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 7850335.593% |
| SmileDirectClub, Inc. | -186.13 Million USD | 17213.555% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | -7013.28% |
| SheerVision, Inc. | -110.53 Thousand USD | 28820069.058% |
| United Health Products, Inc. | -2.5 Million USD | 1273172.567% |
| Vasamed, Inc. | -4.57 Million USD | 696469.087% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 1409154.396% |
| Yubo International Biotech Limited | -1.17 Million USD | 2704980.588% |